Its Not Recommended by Either the FDA or the Drug Maker Both the US Food and Drug Administration (FDA) and Novo Nordisk, the maker of Wegovy and Ozempic, have warned against splitting semaglutide doses exactly for the reasons weve outlined above: its not sterile, it introduces too much room for error, and it can increase the risk of side effects
Residual bloating tends to be mild and predictable, usually related to specific dietary choices rather than the medication itself
User reviews consistently show less effectiveness, less consistency, and less total weight loss compared to injections
MS contributed to study design, collected and analyzed data, and wrote the manuscript
methylcobalamin Vitamin B 12 is known by several names, depending on its chemical form and usage